Skip to main content

Table 3 Estimated parameter values for patients 8-15

From: Personalized life expectancy and treatment benefit index of antiretroviral therapy

Par. P8 P9 P10 P11 P12 P13 P14 P15
β λ 108.12 109.99 127.17 107.15 174.51 112.38 139.62 113.85
β k 1619.24 1444.27 1170.06 1626.31 1586.35 1490.67 1660.41 1576.88
α λ 0.03 0.13 0.22 0.04 0.13 0.06 0.05 0.08
α k 1.18 1.10 0.93 1.09 1.23 1.09 1.17 1.18
T m 3128.4 4026.7 3701.9 3118.1 3254.5 3952.6 4300.6 3220.4
η 0.99 0.87 0.95 0.94 0.96 0.93 0.93 0.95
τ 50 30 30.09 30.71 53.27 30.22 55.79 39.33 65.58
τ m 21897 18753 21340 20003 21530 17541 21454 20267
q 0.55 0.65 0.88 0.58 0.90 0.76 0.53 0.57
p 4.65 4.98 3.25 2.61 3.30 2.11 3.04 2.18
\(\bar {\beta }_{k}\) 746.11 619.94 961.22 189.82 1164.1 1321.1 814 772.8
\(\bar {\alpha }_{k}\) 1.18 1.09 0.87 1.09 1.13 0.93 0.66 1.11
l 0.92 0.86 0.84 0.92 0.83 0.93 0.81 0.93
T s 2441.4 3498.6 3445.7 2472.7 2599.4 3002 3215.7 2569
T r 4526.31 5048.56 4863.17 2872.21 3906.73 4790.24 4418.25 4498.8
T e 7268.8 6339.7 6938.3 5054.7 6722.5 5473 6294.4 4708.4
T d 24338.38 22251.46 24785.25 22476.19 24129.89 20542.58 24669.66 22835.56
B CD4 200 200 150 200 300 300 200
  1. where Par. represents parameter, and Pi denote Patient i